Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022

Rhea-AI Summary

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is set to release its first quarter 2022 financial results on May 4, 2022, after market close. A conference call and webcast will follow at 4:30 PM ET (1:30 PM PT) to discuss the outcomes. Investors can dial in using (855) 427-4396 for toll-free and (484) 756-4261 for international access, with the conference ID being 2354706. An archived version of the webcast will be available for 30 days post-event on their Investor Center website.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2022 results after the financial markets close on Wednesday, May 4, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2022 financial and operating results.

Conference Call/Webcast Details:

Date: May 4, 2022
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 2354706
Webcast Link: https://edge.media-server.com/mmc/p/i8hq38ud

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220411005620/en/

Media Contact:

Steve Sabicer

714-907-6264

ssabicer@thesabicergroup.com

Investor Contact:

Susan Morrison

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When will Tandem Diabetes Care announce its Q1 2022 results?

Tandem Diabetes Care will announce its Q1 2022 results on May 4, 2022.

What time is the conference call for the Q1 2022 results?

The conference call will take place at 4:30 PM ET on May 4, 2022.

How can I access the webcast for Tandem Diabetes Care's financial results?

You can access the webcast through Tandem Diabetes Care's Investor Center or directly via the provided link in the press release.

What is the conference ID for the Tandem Diabetes Care call?

The conference ID for the call is 2354706.